Skip to main content

IUD Insertion

0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Aspivix
AspivixSwitzerland - Epalinges
3 programs
Traction of the cervix for IUD insertionN/A1 trial
cervical tenaculumN/A
cervical vacuum tenaculumN/A1 trial
Active Trials
NCT04441281Completed120Est. Feb 2022
NCT04441333Completed13Est. Dec 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
AspivixTraction of the cervix for IUD insertion
Aspivixcervical vacuum tenaculum

Clinical Trials (2)

Total enrollment: 133 patients across 2 trials

NCT04441281AspivixTraction of the cervix for IUD insertion

Usability, Safety and Efficacy of AspivixTM (Comparative Study)

Start: Apr 2021Est. completion: Feb 2022120 patients
N/ACompleted
NCT04441333Aspivixcervical vacuum tenaculum

Usability, Safety and Efficacy of AspivixTM

Start: Jul 2020Est. completion: Dec 202013 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.